Having trouble accessing articles? Reset your cache.

Cypress Bioscience, Ramius LLC deal

Ramius LLC proposed to acquire the 90.1% of Cypress it does not already own for $4 per share in cash.

Read the full 204 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE